Affiliation:
1. Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Abstract
Tuberculosis kills 1.5 million people each year, and resistance to commonly used antibiotics contributes to treatment failures. The therapeutic potential of bacteriophages against
Mycobacterium tuberculosis
offers prospects for shortening antibiotic regimens, provides new tools for treating multiple drug-resistant (MDR)-TB and extensively drug-resistant (XDR)-TB infections, and protects newly developed antibiotics against rapidly emerging resistance to them.
Funder
HHS | National Institutes of Health
Howard Hughes Medical Institute
The Fowler Fund for Phage Research
Publisher
American Society for Microbiology
Cited by
55 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献